Peritoneal Dialysis: How Hong Kong's PD-First Policy is Changing Kidney Care
"Explore the success, challenges, and future of peritoneal dialysis in Hong Kong, a global leader in PD-first kidney care policies."
In 2012, Hong Kong faced a significant health challenge with 165 new cases of end-stage renal disease (ESRD) per million people, and a total prevalence of 1,192 cases per million. Dialysis emerged as a critical lifeline for many, but how dialysis is approached varies widely by country. Hong Kong stands out with its peritoneal dialysis (PD)-first policy, where over 70% of dialysis patients are treated with PD—the highest rate in the world.
The PD-first policy isn't new. It started decades ago, driven by the need to manage costs and improve patient outcomes. Hemodialysis (HD) is more than twice as expensive as PD, making PD an economically sound choice for widespread treatment. This approach requires a strong medical team, dedicated staff, and thorough patient training to ensure success.
This article explores the key components that make Hong Kong's PD-first policy work. We will examine the challenges, such as managing peritonitis and ultrafiltration failure, and discuss the importance of HD as a backup. Furthermore, we look at organ transplantation as a crucial element in sustaining effective kidney care.
The Growing Burden of End-Stage Renal Disease
End-stage renal disease affects a significant population requiring dialysis or transplantation. In 2024, 22,916 people on dialysis received a kidney transplant, with a transplant rate of 4 per 100 person-years among those on dialysis. The United States Renal Data System collects, analyzes, and distributes information about chronic kidney disease and end-stage renal disease. The economic impact is substantial—The Kidney Project estimates that a bioartificial kidney could save the Medicare budget $15 billion annually once available to eligible patients.
Evolving Indications and Patient-Centered Prescribing
Peritoneal dialysis (PD) has undergone a paradigm shift in indications. Medical barriers previously viewed as contraindications—such as anuria, autosomal dominant polycystic kidney disease, cardiovascular disease, and advanced age—are increasingly being re-examined. The PDOPPS international prospective cohort study examines PD patients across multiple countries including Australia/New Zealand, Canada, Japan, and the USA. ISPD practice recommendations emphasize that delivery of high-quality PD requires a person-centred, individualized shared decision-making approach, tailoring prescriptions to the patient's well-being, lifestyle, and quality of life.
The Ancient Roots and Modern Evolution of Peritoneal Dialysis
The concept of peritoneal dialysis is nearly a century old, with the term 'peritoneum' deriving from the Greek peritonaion, meaning 'to stretch around.' The first known recorded reference of the peritoneal cavity appears in the Ebers papyrus dating to 1550 BC. As a home-based dialysis modality, PD has for decades provided flexibility that helps end-stage kidney disease patients maintain their everyday activities, work, and travel. The historical milestones from PD's early days to the present day reflect a continuous evolution in renal replacement therapy approaches.
Why Prioritize Peritoneal Dialysis? Understanding the PD-First Approach
The PD-first policy in Hong Kong began in 1985, after the Central Renal Committee standardized renal services. Peritoneal dialysis was promoted as the primary treatment option for all patients with chronic kidney disease needing dialysis. This decision was based on the proven cost-effectiveness of PD and its potential to deliver positive outcomes. Patients are introduced to both PD and HD during pre-dialysis education, but the Hospital Authority only covers HD if PD is medically unsuitable. Patients can opt for HD at their own expense.
- Patient Survival: Early studies showed a survival advantage with PD, but recent analyses adjust for patient selection bias.
- Residual Renal Function (RRF): PD helps maintain RRF longer than HD, contributing to better overall health and survival.
- Infection Issues: Hong Kong's low peritonitis rates are attributed to the use of disconnect and double-bag systems.
Policy-Driven Growth in Peritoneal Dialysis Use
Recent years have seen continued growth in peritoneal dialysis use as a kidney replacement therapy, driven largely by policy and payment reforms. In the United States, the End-Stage Renal Disease Prospective Payment System and the Advancing American Kidney Health Initiative have been significant drivers of PD adoption. PD offers several potential benefits over in-center hemodialysis, including greater flexibility and autonomy for patients. Peritoneal dialysis remains the preferred modality for most children with end-stage renal disease, with advances in treatment leading to increased technique and patient survival.
Challenges in Peritoneal Dialysis Outcomes and Retention
Despite its advantages, peritoneal dialysis faces significant challenges. Less than 20% of patients with end-stage kidney disease worldwide are treated with PD, suggesting barriers to broader adoption. While observational studies suggest a survival advantage for PD over hemodialysis in the initial 2-3 years, several medical and non-medical reasons may limit access to and continuation of the modality. Mechanical complications such as dialysate leaks through hernial defects or patent processus vaginalis represent ongoing technical challenges that can lead to PD discontinuation.
Balancing Approaches in Kidney Replacement Therapy
Kidney replacement therapy options continue to evolve as healthcare systems seek to optimize patient outcomes and resource utilization. Different dialysis modalities offer distinct trade-offs in terms of patient autonomy, clinical outcomes, healthcare costs, and quality of life. Policy frameworks increasingly influence which modalities are prioritized, with some regions exploring incentive structures to promote home-based therapies. The evidence base for comparing modalities remains an active area of research, with ongoing debates about optimal patient selection and long-term outcomes across different populations and healthcare settings.
Looking Ahead: Sustaining and Enhancing PD Programs
Hong Kong's success with PD shows that focusing on home-based care can improve patient outcomes and reduce healthcare costs. By tackling issues like peritonitis and ultrafiltration failure, and ensuring adequate HD support, we can meet the growing demands for dialysis. Promoting organ donation remains crucial to offer more patients the chance of a healthier future through transplantation. With dedicated staff, advanced training, and ongoing support, the PD-first policy can continue to lead the way in kidney care.
Expert Perspectives on Dialysis Policy Evolution
The global nephrology community continues to debate the optimal balance between hemodialysis and peritoneal dialysis access. Experts increasingly recognize that dialysis modality selection should be individualized based on clinical factors, patient preferences, and healthcare system capabilities. The shift toward home-based therapies reflects broader trends in medicine toward patient empowerment and decentralized care delivery. Ongoing collaboration between international societies and researchers aims to establish evidence-based guidelines that balance clinical outcomes with practical implementation considerations.
Emerging Frontiers in Peritoneal Dialysis Innovation
Advances in peritoneal dialysis technology and practice continue to expand what is possible for patients with end-stage kidney disease. Innovations in biocompatible solutions, automated systems, and patient monitoring technologies may further improve outcomes and patient experience. The development of bioartificial kidney technologies represents a potentially transformative breakthrough that could fundamentally change the treatment landscape. Research into peritoneal membrane biology and personalized prescription strategies promises to enhance the precision and effectiveness of PD therapy.
Healthcare System Considerations in Dialysis Access
Healthcare systems worldwide face the challenge of providing equitable access to quality dialysis care while managing有限 resources. Reimbursement models, workforce training, and infrastructure requirements significantly influence which dialysis modalities are available and accessible to patients. Disparities in dialysis access persist across different regions and populations, reflecting broader healthcare equity challenges. Policy decisions about dialysis modality mix have implications for healthcare costs, patient outcomes, and system resilience that require careful consideration of local contexts and needs.
Patient Experiences and Quality of Life in Dialysis
Beyond clinical metrics, the impact of dialysis on patients' daily lives, mental health, and social participation remains a critical consideration. Home-based dialysis modalities like PD can offer greater flexibility and independence, potentially improving quality of life for suitable patients. However, the transition to home therapy requires patient education, support systems, and adaptation that not all patients may be able to navigate successfully. The human experience of dialysis—including treatment burden, lifestyle disruption, and psychosocial factors—should remain central to discussions about optimal care approaches and policy frameworks.